子宫内膜癌管理的最新进展
Recent Advances in Endometrial Cancer Management.
作者信息
Di Donato Violante, Giannini Andrea, Bogani Giorgio
机构信息
Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy-Policlinico Umberto I, Viale Regina Elena, 328, 00161 Roma, RM, Italy.
出版信息
J Clin Med. 2023 Mar 14;12(6):2241. doi: 10.3390/jcm12062241.
Abstract
In recent years, growing attempts have been carried out to improve the quality of care in the setting of gynecologic oncology, and, in particular, in endometrial cancer management [...].
摘要
近年来，人们越来越多地尝试提高妇科肿瘤治疗的质量，尤其是在子宫内膜癌的管理方面[...]。
相似文献
1
Recent Advances in Endometrial Cancer Management.子宫内膜癌管理的最新进展
J Clin Med. 2023 Mar 14;12(6):2241. doi: 10.3390/jcm12062241.
2
Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.机器人辅助微创手术在妇科和泌尿外科肿瘤学中的应用：一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(27):1-118. Epub 2010 Dec 1.
3
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations.子宫内膜癌：妇科肿瘤学学会基于证据的综述和推荐。
Gynecol Oncol. 2021 Mar;160(3):817-826. doi: 10.1016/j.ygyno.2020.12.021. Epub 2021 Jan 27.
4
Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice.提高妇科肿瘤护理质量并降低成本。妇科肿瘤学会临床实践建议。
Gynecol Oncol. 2015 May;137(2):280-4. doi: 10.1016/j.ygyno.2015.02.021. Epub 2015 Feb 28.
5
Progress in endometrial cancer: Contributions of the former Gynecologic Oncology Group.子宫内膜癌的研究进展：前妇科肿瘤学组的贡献。
Gynecol Oncol. 2020 May;157(2):312-322. doi: 10.1016/j.ygyno.2020.01.012. Epub 2020 Feb 1.
6
Asian Society of Gynecologic Oncology International Workshop 2014.亚洲妇科肿瘤学会国际研讨会 2014 年。
J Gynecol Oncol. 2015 Jan;26(1):68-74. doi: 10.3802/jgo.2015.26.1.68.
7
Management and Recommendations for Future Pregnancy in Patients with Early-Stage Endometrial Cancer: A Survey of Gynecologic Oncologists and Reproductive Endocrinology and Infertility Specialists.早期子宫内膜癌患者的未来妊娠管理和建议：妇科肿瘤学家和生殖内分泌与不孕专家的调查。
J Adolesc Young Adult Oncol. 2021 Dec;10(6):654-660. doi: 10.1089/jayao.2020.0228. Epub 2021 May 6.
8
Gynecologic oncology group trials in uterine corpus malignancies: recent progress.妇科肿瘤学组在子宫体恶性肿瘤中的临床试验：最新进展。
J Gynecol Oncol. 2008 Dec;19(4):218-22. doi: 10.3802/jgo.2008.19.4.218. Epub 2008 Dec 29.
9
The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report.第 34 届韩国妇科肿瘤学会年会 2019 年会议报告。
J Gynecol Oncol. 2019 Jul;30(4):e91. doi: 10.3802/jgo.2019.30.e91.
10
Insurance-Mediated Disparities in Gynecologic Oncology Care.保险介导的妇科肿瘤学护理差异。
Obstet Gynecol. 2022 Feb 1;139(2):305-312. doi: 10.1097/AOG.0000000000004643.
引用本文的文献
1
Mismatch Repair Protein Deficiency and Its Relationship with Clinicopathological Factors in Endometrial Cancer: A Retrospective Study.错配修复蛋白缺陷及其与子宫内膜癌临床病理因素的关系：一项回顾性研究
J Cancer. 2025 Jun 12;16(9):2778-2786. doi: 10.7150/jca.112935. eCollection 2025.
2
Clinical Application of Next-Generation Sequencing for Molecular Classification in the Management of Endometrial Cancer: An Observational Cohort Study.下一代测序在子宫内膜癌管理中分子分类的临床应用：一项观察性队列研究
Cancers (Basel). 2025 May 28;17(11):1806. doi: 10.3390/cancers17111806.
3
Proteomic Changes Associated With Endogenous FBXW7 Mutations in Moderately Differentiated Endometrial Cancer Cells Include Increased TROP2 and Galectin-3 Levels.与中度分化子宫内膜癌细胞内源性FBXW7突变相关的蛋白质组学变化包括TROP2和半乳糖凝集素-3水平升高。
Cancer Med. 2025 Mar;14(6):e70765. doi: 10.1002/cam4.70765.
4
Penfluridol targets septin7 to suppress endometrial cancer by septin7-Orai/IP3R-Ca-PIK3CA pathway.五氟利多通过septin7-Orai/IP3R-Ca-PIK3CA通路靶向septin7以抑制子宫内膜癌。
iScience. 2024 Dec 19;28(1):111640. doi: 10.1016/j.isci.2024.111640. eCollection 2025 Jan 17.
5
Prediction of HIF-1α expression in endometrial carcinoma by enhanced T weighted angiography and dynamic contrast-enhanced magnetic resonance imaging.通过增强T加权血管造影和动态对比增强磁共振成像预测子宫内膜癌中HIF-1α的表达
Front Oncol. 2024 Dec 11;14:1439229. doi: 10.3389/fonc.2024.1439229. eCollection 2024.
6
Case report: a rare case of duodenal metastasis of endometrial carcinosarcoma.病例报告：一例罕见的子宫内膜癌肉瘤十二指肠转移病例。
Front Oncol. 2024 Oct 15;14:1462029. doi: 10.3389/fonc.2024.1462029. eCollection 2024.
7
Multimodal MRI-based radiomics models for the preoperative prediction of lymphovascular space invasion of endometrial carcinoma.基于多模态 MRI 的放射组学模型用于术前预测子宫内膜癌的淋巴管血管侵犯。
BMC Med Imaging. 2024 Sep 20;24(1):252. doi: 10.1186/s12880-024-01430-1.
8
Clinicopathological characteristics of endometrial carcinoma with different molecular subtypes and their correlation with lymph node metastasis.不同分子亚型子宫内膜癌的临床病理特征及其与淋巴结转移的相关性
Am J Cancer Res. 2024 Aug 25;14(8):3994-4003. doi: 10.62347/FPUJ8382. eCollection 2024.
9
Camrelizumab plus apatinib in patients with advanced or recurrent endometrial cancer after failure of at least one prior systemic therapy (CAP 04): a single-arm phase II trial.卡瑞利珠单抗联合阿帕替尼治疗至少一线治疗失败的晚期或复发性子宫内膜癌患者（CAP04）：一项单臂、II 期临床试验。
BMC Med. 2024 Aug 26;22(1):344. doi: 10.1186/s12916-024-03564-z.
10
A prediction model based on deep learning and radiomics features of DWI for the assessment of microsatellite instability in endometrial cancer.基于深度学习和 DWI 放射组学特征的预测模型用于评估子宫内膜癌的微卫星不稳定性。
Cancer Med. 2024 Aug;13(16):e70046. doi: 10.1002/cam4.70046.
本文引用的文献
1
Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives.基因组学和分子生物学在子宫内膜癌治疗调控中的作用：叙述性综述与展望
Healthcare (Basel). 2023 Feb 15;11(4):571. doi: 10.3390/healthcare11040571.
2
Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice.从癌症基因组图谱（TCGA）到临床实践的子宫内膜癌分子剖析
J Natl Compr Canc Netw. 2023 Feb;21(2):210-216. doi: 10.6004/jnccn.2022.7096.
3
Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward?妇科肿瘤的预防与筛查进展：我们在前进吗？
Healthcare (Basel). 2022 Aug 24;10(9):1605. doi: 10.3390/healthcare10091605.
4
The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis.SLN 映射联合吲哚菁绿在低危和中危子宫内膜癌管理中的附加价值：系统评价和荟萃分析。
J Gynecol Oncol. 2022 Sep;33(5):e66. doi: 10.3802/jgo.2022.33.e66. Epub 2022 Jun 28.
5
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.多塔利单抗治疗晚期或复发性 DNA 错配修复缺陷/微卫星不稳定高（dMMR/MSI-H）或 proficient/stable（MMRp/MSS）子宫内膜癌患者的安全性和抗肿瘤活性：GARNET 研究的初步结果，一项 I 期单臂研究。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003777.
6
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.仑伐替尼联合帕博利珠单抗治疗晚期子宫内膜癌。
N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19.
7
Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study.前哨淋巴结低容量转移的子宫内膜癌患者的肿瘤学结局：一项国际多机构研究。
Gynecol Oncol. 2021 Sep;162(3):590-598. doi: 10.1016/j.ygyno.2021.06.031. Epub 2021 Jul 15.
8
Uterine serous carcinoma.子宫浆液性癌。
Gynecol Oncol. 2021 Jul;162(1):226-234. doi: 10.1016/j.ygyno.2021.04.029. Epub 2021 Apr 30.
9
Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study.高危型子宫内膜癌患者中前哨淋巴结绘图与前哨淋巴结绘图加后备淋巴结切除术的对比：一项多机构研究的结果。
Gynecol Oncol. 2021 Apr;161(1):122-129. doi: 10.1016/j.ygyno.2021.01.008. Epub 2021 Jan 20.
10
Low-volume disease in endometrial cancer: The role of micrometastasis and isolated tumor cells.子宫内膜癌中的低容量疾病：微转移和孤立肿瘤细胞的作用。
Gynecol Oncol. 2019 Jun;153(3):670-675. doi: 10.1016/j.ygyno.2019.02.027. Epub 2019 Mar 1.
Zotero 插件